|Stock Availability||In stock|
|Brand Name||Look chem|
Edaravone is a nootropic and neuroprotective agent used to aid nervous system recovery after acute cerebral ischemia and subsequent cerebral infarction.
The product was first listed in Japan in April 2001, and is mainly used for the treatment of ischemic stroke in clinical practice.
Edaravone exists in the form of anion and can donate one electron to free radicals to achieve the purpose of scavenging free radicals.
Because its molecular structure contains lipophilic groups, it can easily reach the brain tissue through the blood-brain barrier, and has a protective effect on nerve cell damage caused by cerebral ischemia.
Clinical studies of Edaravone suggest that N-acetylaspartic acid (NAA) is a specific marker of surviving nerve cells, and its content is sharply reduced in the early stage of cerebral infarction.
Edaravone has been shown to attenuate methamphetamine- and 6-OHDA-induced dopaminergic neurotoxicity in the striatum and substantia nigra and did not affect methamphetamine-induced dopamine release or hyperthermia.
It has also been shown to prevent MPTP-mediated dopaminergic neurotoxicity in the substantia nigra, but not in the striatum in particular.
Edaravone is mainly used to synthesize pyrazolone antipyretic analgesics such as dipyrone, antipyrine and aminopyrine.
It is also an intermediate of pyrazolone acid dyes such as acid medium jujube red BN, permanent yellow G and color film dyes, pesticides and other fine chemicals.
Edaravone can be used as a reagent for the determination of cobalt, copper, iron, nickel, silver and vitamin B12.
It can be used as an environmentally friendly reagent and a reagent for ESI/MALDI-MS detection of reducing carbohydrates.
Used in the production of pyrazolone acid dyes such as acid bordeaux BN, acid mordant B, orange GR, weak acid bright yellow G, neutral burgundy D-BN, permanent yellow G, leather spray red GL, orange 2RL, brown 2RL / Active disperse bright yellow 3G, yellow brown M-3GR, etc.
Currently, edaravone is mainly used for the treatment of ischemic stroke.
However, its free radical scavenging and antioxidant effects have been confirmed, and various experimental studies have also shown that edaravone has a protective effect on other organ damage.
It is suggested that the role of it is not only limited to the treatment of ischemic stroke, but also plays a role in the treatment of various diseases closely related to oxidative stress.
Japan, as the original research country, is also used in multiple departments in the application of edaravone, such as neurology, brain surgery, cardiology, internal medicine, thoracic surgery, emergency department, surgery, respiratory department, gastroenterology, plastic surgery and pediatrics.
The specific application areas of Edaravone are as follows:
In addition, there are diabetic peripheral neuropathy in endocrinology;
ENT, ischemic optic nerve injury;
Protection of lungs during thoracotomy in thoracic surgery;
The protection of multiple organs during anesthesia surgery, and its application in oncology and organ transplantation.
I’m william, CEO of Look Chemical Co., Ltd. Welcome to visit our company. As China’s top Global Supply Specialist of chemicals, we have always been adhering to the principle of “service first, quality first, mutual benefit”, and we insist on Create value for customers and grow together with customers.
In the past few years , we have provided efficient and satisfactory services to more than 6000 customers and have been widely praised internationally. In the future, we will strive to provide more than 100,000 customers with professional and thoughtful services, and strive to become your first choice for worry-free purchasing chemicals in China , Hope to bring you a good cooperation experience. If you have any questions, please feel free to contact us.